Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

Stage-four cancer patients are living longer, challenging the idea of what it means to have and survive cancer. “The science ...

Detailed price information for Nuvation Bio Inc (NUVB-N) from The Globe and Mail including charting and trades.

Nuvation Bio To Present New Data on IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses ...

"If approved, the GM Purple Tomato will be sold fresh, as a whole tomato, or used as an ingredient in processed food products such as sun-dried tomatoes or pastes," it said.

To detect ROS1 rearrangement in NSCLC, three different assays including fluorescent in stiu hybridization (FISH), Amoy Dx reverse transcription polymerase chain reaction (RT-PCR) and Oncomine Dx ...

Aligned with FDA on NDA submission strategy for TKI pre-treated patients with advanced ROS1-positive NSCLC and participation in Real-Time Oncology Review; the company ...

The completed Phase 1 portion enrolled ROS1-positive NSCLC patients who previously received at least one ROS1 TKI, or patients with other ROS1-positive solid tumors who had been previously treated.

Aligned with FDA on NDA submission strategy for TKI pre-treated patients with advanced ROS1-positive NSCLC and participation in Real-Time Oncology Review; the company plans to initiate a rolling ...

Nuvalent is eyeing an FDA rolling submission for its ROS1 inhibitor in TKI-pretreated lung cancer after releasing competitive pivotal data.